More than 35,000 men are diagnosed with prostate cancer each year in the UK alone – and approximately 10,000 deaths per year are associated with this form of cancer.
The sooner prostate cancer is diagnosed the better a patient’s chances of rapid recovery will be. However, the development of prostate cancer at an early stage is often very difficult to diagnose, depending on where the cancer is located.
See3D’s visualisation project, commissioned by medical imaging software company Oncomorph Analysis Limited, established by the University of Aberystwyth and Exomedica Ltd., will over the next two years, identify smaller cancerous regions of the prostate that are currently undetectable to doctors by the rapid processing of numerical data. Doctors can then use this information to aid diagnosis and, subsequently, treatment.
Doctors have three treatment options once prostate cancer has been diagnosed: to remove the prostate, to deliver chemotherapy and radiology, or, if the cancer is too advanced, then a ‘wait and see’ approach is taken. The visualisation software developed during the Oncomorph Analysis project will also be used for treatment planning, as it will enable doctors to investigate the development of the cancer and thus determine the best treatment option.
Dr Reyer Zwiggelaar, Senior Lecturer in Computer Science at the University of Aberystwyth and Chief Scientific Officer of Oncomorph Analysis – who is leading the project with the See3D team, said: “Once developed, this software application will be unique in the world. From our collaborative work with hospitals in Norwich and Swansea we know that our software analysis and visualisation programme will make a real difference to the important work of doctors in combating cancer by enabling them to diagnose cases earlier and improve patients’ chances of recovery.”
Dr. Mark Fisher, Chairman of Oncomorph Analysis, said “We are pleased to be working with See3D and their team of experienced software engineers. Product development, with See3D’s help, will produce a truly enabling tool for medical device manufacturers and the end user – the doctor.”
David Neill, Director of See3D, said: “We are exteremly grateful to Oncomorph Analysis for funding this important project. It will allow us to play a major role in helping to tackle the detection of prostate cancer, which has become one of the biggest killers for men. Our advanced computer modelling equipment can provide great insights for the healthcare sector, along with other sectors such as renewable energy, heritage and construction where we are already operating.”
UTSA study describes new minimally invasive device to treat cancer and other illnesses
02.12.2016 | University of Texas at San Antonio
Earlier Alzheimer's diagnosis may be possible with new imaging compound
02.11.2016 | Washington University School of Medicine
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
05.12.2016 | Power and Electrical Engineering
05.12.2016 | Materials Sciences
05.12.2016 | Power and Electrical Engineering